Lantern Pharma Inc. (LTRN) › Total LiabilitiesLantern Pharma Inc. (LTRN) — Total LiabilitiesAnnual figures by period end, from SEC filings.2019-12-31: $489.3K2020-12-31: $660.8K2021-12-31: $2.38M2022-12-31: $2.80M2023-12-31: $2.74M2024-12-31: $4.38M2025-12-31: $4.50M$4.50M2019-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$4.50M+2.7%2026-03-30Balance as of period end2024-12-31$4.38M+60.0%2026-03-30Balance as of period end2023-12-31$2.74M-2.1%2025-03-27Balance as of period end2022-12-31$2.80M+17.6%2024-03-18Balance as of period end2021-12-31$2.38M+260.0%2023-03-20Balance as of period end2020-12-31$660.8K+35.1%2022-03-10Balance as of period end2019-12-31$489.3K—2021-03-10Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)